http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4010703-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aeaca73a3ec1ea19201f07899c63aaf |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 |
filingDate | 2020-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f46892480d7e0a648270015f19308e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f251ef584d516a1b22be4660d5f8a6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecafa3037722ce63068beef13530d6ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e08c76023ee058fbde85d79b5574151 |
publicationDate | 2022-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-4010703-A1 |
titleOfInvention | A method and reagents for the diagnosis of mn |
abstract | The present invention relates to a method comprising the step detecting an autoantibody to PLA2R in a sample comprising antibodies from a patient at a concentration range including 0.5 to 14 RU/ml, wherein the sample is contacted with a polypeptide comprising PLA2R or a variant thereof under conditions that allow for the formation of a complex comprising the autoantibody and PLA2r, wherein the complex is immobilized and detected; a diagnostically useful carrier comprising recombinant and/or purified human PLA2R or a variant thereof, wherein the carrier is capable of capturing an autoantibody to PLA2R for detection at a concentration below 14 RU/ml, and wherein the carrier selected from the group comprising a Western Blot membrane and a bead, preferably a magnetic bead; and a kit comprising the diagnostically useful carrier according to claim 13 and a means for detecting an autoantibody present in a sample at a concentration range below 14 RU/ml, which is a secondary antibody labeled with a detectable radioactive or chemiluminescent label. |
priorityDate | 2019-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.